2023 Partnering in Patents | Pre-Meeting Event
2023 Partnering in Patents October- Virtual
October 18, 2023 10:00 AM to 3:30 PM
Location
Credits
No CLE
Registration
The USPTO and AIPLA are hosting the 30th Annual Partnering in Patents event remotely as a pre-conference event to our Annual Meeting. This virtual, one day program fosters an open dialog between AIPLA members and the USPTO.
The program has two parts: a morning focus session, and the afternoon program. There is a separate registration for each part. Links to both are below.
AGENDA
10:00-11:30 AM virtual focus session - (This session is full, however you may still register for the afternoon panels.)
In virtual roundtables, a mix of practitioners and USPTO members will discuss 3-4 topics to generate ideas and best-practice suggestions. These sessions are limited to 80 participants. If you are interested in this session, please register using the separate link above. We are looking for an even number of outside practitioners and USPTO participants.
12:00-3:30 - Welcome remarks followed by three 1-hour panels (no seat limit): To register for the afternoon panels, please click here.
- USPTO updates on programs and initiatives
- Prosecution perspectives from a panel of PTO personnel and practitioners
- Interactive quiz show and discussion of past focus session topics
News
-
AIPLA Comments on CNIPA Draft Measures for Prioritized Patent Examination
April 1, 2026
Arlington, VA. March 30, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the China National Intellectual Property Administration (CNIPA) regarding the Draft Measures for the Administration of Prioritized Examination of Patents. -
AIPLA Files Amicus Brief in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc
March 31, 2026
Arlington, VA. March 27, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus curiae brief with the Supreme Court in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., No. 24-889. AIPLA urges the Court to affirm the Federal Circuit’s application of the established Iqbal/Twombly pleading standard and inducement law in reviewing Hikma’s motion to dismiss Amarin’s claim that Hikma’s conduct, in combination with its “skinny label,” induced infringement of Amarin’s patented treatment methods. -
Supreme Court Issues Unanimous Decision in Cox Communications, Inc. v. Sony Music Entertainment
March 25, 2026
On March 25, 2026, the Supreme Court issued a unanimous decision in Cox Communications, Inc. v. Sony Music Entertainment. The majority opinion limits contributory liability to situations where a party intended that its service be used for infringement, either by affirmatively inducing infringement or by selling a service tailored to infringement. A concurring opinion by Justice Sotomayor argues that the material contribution test should be retained, and that other forms of secondary liability can be found, which is consistent with the position asserted by AIPLA in its amicus brief filed on September 5, 2025. To read the opinion of the Court, please click here. -
AIPLA Comments on the Draft Trademark Law of the People’s Republic of China
March 23, 2026
Arlington, VA. February 9, 2026 – The American Intellectual Property Law Association (AIPLA) submitted comments to the Legislative Affairs Commission of the Standing Committee of the National People’s Congress regarding the latest Draft Trademark Law of the People’s Republic of China. AIPLA recognized the NPC’s efforts to streamline trademark procedures, strengthen protection, and address abusive and bad-faith filing practices. -
AIPLA Files Amicus Brief in USAA v. PNC Bank
March 3, 2026
Arlington, VA. March 2, 2026 – The American Intellectual Property Law Association (AIPLA) filed an amicus brief with the Supreme Court in USAA v. PNC Bank, N.A., No. 25-853, in support of USAA’s petition for certiorari, urging the Court to provide much-needed guidance to address the unpredictable and overly broad application of the judicial exceptions to patent-eligible subject matter under 35 U.S.C. § 101, particularly the “abstract idea” exception.
